Compound Summary
Compound Name: | 10-Hydroxy-2-decenoic acid |
Compound CID: | 5312738 |
Synonyms: | 10-Hydroxy-2-decenoic acid 14113-05-4 10-hydroxydec-2-enoic acid Royal jelly acid 765-01-5 More... |
Iupac Name: | (E)-10-hydroxydec-2-enoic acid |
InChI: | InChI=1S/C10H18O3/c11-9-7-5-3-1-2-4-6-8-10(12)13/h6,8,11H,1-5,7,9H2,(H,12,13)/b8-6+ |
InChIKey: | QHBZHVUGQROELI-SOFGYWHQSA-N |
Canonical Smiles: | C(CCCC=CC(=O)O)CCCO |
Isomeric Smiles: | C(CCC/C=C/C(=O)O)CCCO |
Molecular Weight: | 186.25 |
Molecular Formula: | C10H18O3 |
Molecular Weight: | 186.25 |
Molecular Formula: | C10H18O3 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 8 |
Heavy Atom Count: | 13 |
Complexity: | 152 |
10-Hydroxy-2-decenoic acid | 10-Hydroxy-2-decenoic acid |
---|---|
10-Hydroxy-2-decenoic acid |
14113-05-4 |
10-hydroxydec-2-enoic acid |
Royal jelly acid |
765-01-5 |
(E)-10-Hydroxy-2-decenoic acid |
Queen Bee Acid |
(E)-10-hydroxydec-2-enoic acid |
10-Hydroxydecenoic acid |
trans-10-Hydroxy-2-decenoic acid |
10-Hydroxy-2-decylenic acid |
2-Decenoic acid, 10-hydroxy-, (2E)- |
10-hydroxy-2E-decenoic acid |
UNII-76B519G7TJ |
10-hydroxy-trans-2-decenoic acid |
10-HDA |
76B519G7TJ |
NSC87516 |
NSC 87516 |
2-Decenoic acid, 10-hydroxy-, (E)- |
SCHEMBL285440 |
10H2DA |
CHEBI:78668 |
10-Hydroxy-2(E)-decenoic acid |
trans-10-hydroxydec-2-enoic acid |
(E)-10-oxidanyldec-2-enoic acid |
(2E)-10-hydroxydec-2-enoic acid |
(EZ)-10-Hydroxydec-2-enoic acid |
AMY22616 |
HY-N1363 |
ZINC1562127 |
10-Hydroxy-2-Decenoic Acid ,(S) |
1909AC |
LMFA01050157 |
MFCD00204506 |
NSC-87516 |
s3827 |
AKOS006282270 |
AKOS025310134 |
(2E)-10-Hydroxy-2-decenoic acid # |
CCG-266478 |
AC-15652 |
AC-34577 |
AS-13924 |
AS-58742 |
O918 |
(E)-10-hydroxydec-2-enoic acid;10-HDA |
AB0016728 |
CS-0016772 |
H1337 |
N-(2,4,6-trichlorophenoxy)ethyl-N-propylamine |
O10366 |
113H054 |
A807734 |
A838726 |
A865474 |
(E)-10-Hydroxy-2-decenoic acid, 98%, from honey |
J-007465 |
Q16908844 |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 25.000000000000000 | umol/L | 34.400000000000000 | 37.700000000000000 | 10.000000000000000 | 49.000000000000000 | 56.000000000000000 | 14.000000000000000 | S | N2 | 25789174 | Active | |
Caenorhabditis elegans | 25.000000000000000 | umol/L | 34.300000000000000 | 36.200000000000000 | 6.000000000000000 | 45.000000000000000 | 50.000000000000000 | 11.000000000000000 | S | N2 | 25789174 | Active | |
Caenorhabditis elegans | 25.000000000000000 | umol/L | 34.800000000000000 | 38.700000000000000 | 11.000000000000000 | 54.000000000000000 | 52.000000000000000 | -4.000000000000000 | S | N2 | 25789174 | Active |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 11.000000000000000 | 14.000000000000000 | 1 | 3 |